Sex Differences in the Prescription of P2Y12 Inhibitor Agents Following Percutaneous Coronary Intervention
In patients with ACS, gender differences in P2Y12 inhibitor use disappeared after 2021, likely reflecting better adherence to current guidelines. However, among those undergoing PCI for non-ACS indications, significant sex disparities in DAPT selection remain.
Authors
- Muzammil Khan
- William Laband (ORCID: https://orcid.org/0009-0006-5744-5635)
- Surik Sedrakyan
Institutions
- Boston Medical Center (US)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1002/ccd.70269
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00